Onconova Therapeutics Inc. (NASDAQ:ONTX) saw an uptick in trading volume on Tuesday . 143,823 shares changed hands during mid-day trading, an increase of 17% from the previous session’s volume of 122,454 shares.The stock last traded at $3.56 and had previously closed at $3.70.

Separately, Maxim Group set a $6.00 price target on Onconova Therapeutics and gave the stock a “buy” rating in a research note on Thursday, August 11th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $24.74.

The company’s market cap is $10.58 million. The firm has a 50 day moving average of $4.22 and a 200-day moving average of $4.78.

Onconova Therapeutics (NASDAQ:ONTX) last released its quarterly earnings results on Monday, August 15th. The biopharmaceutical company reported ($1.96) EPS for the quarter. The company earned $2.25 million during the quarter. Analysts forecast that Onconova Therapeutics Inc. will post ($7.40) earnings per share for the current fiscal year.

Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.